Repositori institucional URV
Español Català English
TITLE:
Increasing the complexity of lipoprotein characterization for cardiovascular risk in type 2 diabetes - imarina:9365691

URV's Author/s:Girona Tell, Josefa / Guardiola Guionnet, Montserrat / Rehues Masip, Pere / Ribalta Vives, Josep
Author, as appears in the article.:Guardiola M; Rehues P; Amigó N; Arrieta F; Botana M; Gimeno-Orna JA; Girona J; Martínez-Montoro JI; Ortega E; Pérez-Pérez A; Sánchez-Margalet V; Pedro-Botet J; Ribalta J
Author's mail:pere.rehues@urv.cat
josefa.girona@urv.cat
pere.rehues@urv.cat
josefa.girona@urv.cat
montse.guardiola@urv.cat
josep.ribalta@urv.cat
Author identifier:0000-0002-6267-8779
0000-0002-6267-8779
0000-0002-9696-7384
0000-0002-8879-4719
Journal publication year:2024
Publication Type:Journal Publications
APA:Guardiola M; Rehues P; Amigó N; Arrieta F; Botana M; Gimeno-Orna JA; Girona J; Martínez-Montoro JI; Ortega E; Pérez-Pérez A; Sánchez-Margalet V; Pedro (2024). Increasing the complexity of lipoprotein characterization for cardiovascular risk in type 2 diabetes. European Journal Of Clinical Investigation, (), e14214-e14214. DOI: 10.1111/eci.14214
Papper original source:European Journal Of Clinical Investigation. e14214-e14214
Abstract:The burden of cardiovascular disease is particularly high among individuals with diabetes, even when LDL cholesterol is normal or within the therapeutic target. Despite this, cholesterol accumulates in their arteries, in part, due to persistent atherogenic dyslipidaemia characterized by elevated triglycerides, remnant cholesterol, smaller LDL particles and reduced HDL cholesterol. The causal link between dyslipidaemia and atherosclerosis in T2DM is complex, and our contention is that a deeper understanding of lipoprotein composition and functionality, the vehicle that delivers cholesterol to the artery, will provide insight for improving our understanding of the hidden cardiovascular risk of diabetes. This narrative review covers three levels of complexity in lipoprotein characterization: 1-the information provided by routine clinical biochemistry, 2-advanced nuclear magnetic resonance (NMR)-based lipoprotein profiling and 3-the identification of minor components or physical properties of lipoproteins that can help explain arterial accumulation in individuals with normal LDLc levels, which is typically the case in individuals with T2DM. This document highlights the importance of incorporating these three layers of lipoprotein-related information into population-based studies on ASCVD in T2DM. Such an attempt should inevitably run in parallel with biotechnological solutions that allow large-scale determination of these sets of methodologically diverse parameters.© 2024 The Authors. European Journal of Clinical Investigation published by John Wiley & Sons Ltd on behalf of Stichting European Society for Clinical Investigation Journal Foundation.
Article's DOI:10.1111/eci.14214
Link to the original source:https://onlinelibrary.wiley.com/doi/10.1111/eci.14214
Papper version:info:eu-repo/semantics/publishedVersion
licence for use:https://creativecommons.org/licenses/by/3.0/es/
Department:Medicina i Cirurgia
Ciències Mèdiques Bàsiques
Licence document URL:https://repositori.urv.cat/ca/proteccio-de-dades/
Thematic Areas:Saúde coletiva
Odontología
Nutrição
Medicine, research & experimental
Medicine, general & internal
Medicine (miscellaneous)
Medicina ii
Medicina i
Interdisciplinar
General medicine
Farmacia
Educação física
Clinical biochemistry
Ciências biológicas iii
Ciências biológicas ii
Ciências biológicas i
Biotecnología
Biochemistry
Keywords:Nmr
Lps
Lipoprotein
Diabetes
Cardiovascular risk
Apoc‐iii
Apoc-iii
Entity:Universitat Rovira i Virgili
Record's date:2024-09-21
Search your record at:

Available files
FileDescriptionFormat
DocumentPrincipalDocumentPrincipalapplication/pdf

Information

© 2011 Universitat Rovira i Virgili